Tsfg, LLC Astrazeneca PLC Transaction History

Tsfg, LLC

$487 Million
Q4 2024

A detailed history of Tsfg, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Tsfg, LLC holds 463 shares of AZN stock, worth $34,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares

463

Previous 463 -0.0%

Holding current value

$34,470

Previous $36,000 16.67%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$76.67 - $87.62 $76 - $87	1 Added 0.22%	463 $36,000
Q1 2024 Apr 16, 2024	BUY	$61.03 - $69.57 $244 - $278	4 Added 0.87%	462 $31,000
Q4 2023 Jan 23, 2024	SELL	$61.89 - $69.28 $618 - $692	-10 Reduced 2.14%	458 $31,000
Q3 2023 Oct 10, 2023	BUY	$64.85 - $71.7 $129 - $143	2 Added 0.43%	468 $32,000
Q2 2023 Jul 10, 2023	BUY	$69.91 - $75.81 $699 - $758	10 Added 2.19%	466 $33,000
Q1 2023 Apr 21, 2023	BUY	$63.15 - $71.6 $252 - $286	4 Added 0.88%	456 $32,000
Q3 2022 Oct 20, 2022	BUY	$53.02 - $135.75 $106 - $271	2 Added 0.44%	452 $25,000
Q1 2022 Apr 25, 2022	BUY	$55.72 - $67.12 $167 - $201	3 Added 0.67%	450 $30,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $7,616 - $9,000	-141 Reduced 23.98%	447 $26,000
Q3 2021 Oct 12, 2021	BUY	$55.56 - $60.79 $111 - $121	2 Added 0.34%	588 $35,000
Q1 2021 Apr 14, 2021	SELL	$47.16 - $54.44 $2,358 - $2,722	-50 Reduced 7.86%	586 $29,000
Q4 2020 Jan 20, 2021	BUY	$48.52 - $58.02 $12,421 - $14,853	256 Added 67.37%	636 $32,000
Q1 2020 Apr 08, 2020	BUY	$37.79 - $51.33 $7,935 - $10,779	210 Added 123.53%	380 $17,000
Q4 2019 Jan 27, 2020	BUY	$42.46 - $50.46 $1,231 - $1,463	29 Added 20.57%	170 $8,000
Q1 2019 Jan 27, 2020	BUY	$35.49 - $43.02 $5,004 - $6,065	141 New	141 $6,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

477M

Call Options Held

5.29M

Put Options Held

3.79M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account